Logo

Innovative Drugs to Restore Neurological Function

Search Btn
  • Home
  • About Us
    • About Us
    • Management
    • Scientific Advisory Board
    • Board of Advisors
  • Disease Focus
    • Technology
    • Spinal Cord Injury
    • Cerebral Vascular Disorder
  • Patients
    • Patients
  • News
  • Contact Us
    • Contact Us

Ron Goldstein Picture

News

August 28, 2020: BioAxone BioSciences Announces License of Cerebral Cavernous Malformation Drug Caandidate BA-1049 and Portfolio of Rho kinase inhibitors to Neurelis Click here for the full story .
September 12, 2019: BioAxone Announces Notice of Allowance for Self-Delivering RNA Interference for the Treatment of Spinal Cord Injury. Click here for the full story.

Events

Jan 23-27 2022. The International Symposium on Neural Regeneration (ISNR) will be held Jan 23-27 at Asilomar Conference Center, Pacific Grove, CA. Dr. Lisa McKerracher, BioAxone's CEO, is a member of the organising committee for this scientific event.

© 2021 BioAxone | 90 Canal Street, 4th Floor | Boston, MA 02114 | Ph: 617-401-3115 | Site by KWWD.co